Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients

gan Funnell, S. G. P., Dowling, W. E., Muñoz-Fontela, C., Gsell, P.-S., Ingber, D. E., Hamilton, G. A., Delang, L., Rocha-Pereira, J., Kaptein, S., Dallmeier, K. H., Neyts, J., Rosenke, K., de Wit, E., Feldmann, H., Maisonnasse, P., Le Grand, R., Frieman, M. B., Coleman, C. M.
Cyhoeddwyd yn Nat Commun (2020)

COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models

gan Maisonnasse, P, Aldon, Y, Marc, A, Marlin, R, Dereuddre-Bosquet, N, Kuzmina, NA, Freyn, AW, Snitselaar, JL, Gonçalves, A, Caniels, TG, Burger, JA, Poniman, M, Chesnais, V, Diry, S, Iershov, A, Ronk, AJ, Jangra, S, Rathnasinghe, R, Brouwer, PJM, Bijl, TPL, van Schooten, J, Brinkkemper, M, Liu, H, Yuan, M, Mire, CE, van Breemen, MJ, Contreras, V, Naninck, T, Lemaître, J, Kahlaoui, N, Relouzat, F, Chapon, C, Ho Tsong Fang, R, McDanal, C, Osei-Twum, M, St-Amant, N, Gagnon, L, Montefiori, DC, Wilson, IA, Ginoux, E, de Bree, GJ, García-Sastre, A, Schotsaert, M, Coughlan, L, Bukreyev, A, van der Werf, S, Guedj, J, Sanders, RW, van Gils, MJ, Le Grand, R
Cyhoeddwyd yn Res Sq (2021)